StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck organon Revenue — Total International ($M) ($M)

Organon & Co. Form 10-Q / 10-K

QuarterlyAnnual
Latest, Q2 2026
1,160,000,000
Period ended Jun 30, 2026
Change on a year earlier
-1.7%
1,180,000,000 in Q2 2025
History
22 quarters
Since Q1 2021
Sources
17
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOrganon Revenue — Total International ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,160,000,000-1.7%Organon & Co. SEC Filing (0001628280-26-051230) ↗
Q1 2026Mar 31, 20261,102,000,000+0.1%Organon & Co. SEC Filing (0001628280-26-029532) ↗
Q4 2025Dec 31, 20251,135,000,000-3.5%Organon & Co. SEC Filing (0001628280-26-011125) ↗
Q3 2025Sep 30, 20251,196,000,000+1.0%Organon & Co. SEC Filing (0001628280-25-050795) ↗
Q2 2025Jun 30, 20251,180,000,000-3.2%Organon & Co. SEC Filing (0001821825-25-000066) ↗
Q1 2025Mar 31, 20251,101,000,000-12.0%Organon & Co. SEC Filing (0001821825-25-000023) ↗
Q4 2024Dec 31, 20241,176,000,000-0.9%Organon & Co. SEC Filing (0001821825-25-000006) ↗
Q3 2024Sep 30, 20241,184,000,000+3.0%Organon & Co. SEC Filing (0001821825-24-000108) ↗
Q2 2024Jun 30, 20241,219,000,000-1.5%Organon & Co. SEC Filing (0001821825-25-000066) ↗
Q1 2024Mar 31, 20241,251,000,000+3.2%Organon & Co. SEC Filing (0001821825-25-000023) ↗
Q4 2023Dec 31, 20231,187,000,000+8.8%Organon & Co. SEC Filing (0001821825-25-000006) ↗
Q3 2023Sep 30, 20231,149,000,000-1.9%Organon & Co. SEC Filing (0001821825-24-000108) ↗
Q2 2023Jun 30, 20231,237,000,000+0.2%Organon & Co. SEC Filing (0001821825-24-000083) ↗
Q1 2023Mar 31, 20231,212,000,000-2.1%Organon & Co. SEC Filing (0001821825-24-000056) ↗
Q4 2022Dec 31, 20221,091,000,000-13.1%Organon & Co. SEC Filing (0001821825-25-000006) ↗
Q3 2022Sep 30, 20221,171,000,000-6.6%Organon & Co. SEC Filing (0001821825-23-000013) ↗

Cite this data

StockData. (2026). Merck Organon Revenue — Total International ($M) ($M), quarterly Q1 2021–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/ogn_geo_intl

See every metric in the Merck KPI table. Data updated Oct 26, 2026.